Atherosclerosis
Volume 193, Issue 2 , Pages 380-388, August 2007

Prospective epidemiologic evidence of a “protective” effect of smoking on metabolic syndrome and diabetes among Turkish women—Without associated overall health benefit

  • Altan Onat

      Affiliations

    • Turkish Society of Cardiology, Nisbetiye cad. 37/24, Etiler 34335, Istanbul, Turkey
    • Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90 212 351 6217; fax: +90 212 351 4235.
  • ,
  • Hakan Özhan

      Affiliations

    • Cardiology Department of I. Baysal U. Düzce, Istanbul, Turkey
  • ,
  • A. Metin Esen

      Affiliations

    • Kosuyolu Heart Hospital, Istanbul, Turkey
  • ,
  • Sinan Albayrak

      Affiliations

    • Cardiology Department of I. Baysal U. Düzce, Istanbul, Turkey
  • ,
  • Ahmet Karabulut

      Affiliations

    • S. Ersek Cardiovascular Surgery Center, Istanbul, Turkey
  • ,
  • Günay Can

      Affiliations

    • Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey
  • ,
  • Gülay Hergenç

      Affiliations

    • S. Ersek Cardiovascular Surgery Center, Istanbul, Turkey
    • Biology Department, Yildiz Technical University, Istanbul, Turkey

Received 1 March 2006; received in revised form 19 June 2006; accepted 6 July 2006. published online 22 August 2006.

Abstract 

Sex-specific effects of cigarette smoking on the development of metabolic syndrome (MS) and diabetes (DM), concomitant with its clinical impact on CHD, were prospectively evaluated in a cohort of 3385 participants (mean age 48 years), representative of Turks. Heavy smoking denoted smoking 11 or more cigarettes daily. During a mean 5.9-year follow-up, 485 incident cases of MS and 216 of DM were diagnosed. Among women, baseline characteristics as a whole were similar. Smoking status was inversely associated with waist circumference (p=0.004) and predicted in women hyperinsulinemia (p=0.045) after adjustment for age and body mass index. In the prediction of MS, heavy smoking was significantly “protective” (RR 0.50 [95% CI 0.26; 0.94]) in women and in both genders combined, after adjustment for age, baseline family income bracket and physical activity grade. As predictor of new DM, heavy smoking was significantly “protective” (RR 0.54 [95% CI 0.35; 0.83]) in all adults and in women (RR 0.13 [95% CI 0.02; 0.97]), after similar adjustment. Additional adjustment for insulin and CRP levels hardly modified in women the RRs, though attenuated to borderline significance risk for MS and DM due to smaller sample size. Risks of incident CHD and overall mortality were significantly elevated in smoking men, but not in women, when adjusted for age, serum total cholesterol, elevated BP, DM and physical activity grade.

Conclusions: Heavy cigarette smoking is “protective” of future MS and DM in Turkish women, mainly via protection from obesity. A separate modest effect on central obesity appeared independent of plasma insulin concentrations. Evidence of a translated beneficial effect on subsequent CHD or all-cause mortality did not emerge.

Keywords: Abdominal obesity, Cigarette smoking, Coronary heart disease, Diabetes type 2, Metabolic syndrome, Proinflammatory state, Prospective population-based study

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0021-9150(06)00399-6

doi:10.1016/j.atherosclerosis.2006.07.002

Atherosclerosis
Volume 193, Issue 2 , Pages 380-388, August 2007